aminoglutethimide has been researched along with Endometrial Neoplasms in 4 studies
Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-nine patients of endometrial cancer were treated with hydroxyprogesterone caproate, AG or combination of both, and their effects were compared." | 2.68 | [Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer]. ( Liu, XS; Zhang, X, 1995) |
| "AG also can be used to treat endometrial carcinoma." | 2.68 | Exploration for drug therapy in endometrial carcinoma. ( Cao, B; Zhang, X, 1996) |
| "Estrogen receptors of human endometrial cancer Ishikawa cells were found to be present in moderate amounts (160-200 fmol/mg protein), and to specifically bind moxestrol (R2858) with a very high affinity characterized by a Kd around 60 pM, when measured under equilibrium conditions." | 1.29 | Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells. ( Botella, J; Delansorne, R; Duc, I; Duranti, E; Paris, J; Viader, V, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spano, JP | 1 |
| Soria, JC | 1 |
| Kambouchner, M | 1 |
| Piperno-Neuman, S | 1 |
| Morin, F | 1 |
| Morere, JF | 1 |
| Martin, A | 1 |
| Breau, JL | 1 |
| Botella, J | 1 |
| Duranti, E | 1 |
| Viader, V | 1 |
| Duc, I | 1 |
| Delansorne, R | 1 |
| Paris, J | 1 |
| Liu, XS | 1 |
| Zhang, X | 2 |
| Cao, B | 1 |
2 trials available for aminoglutethimide and Endometrial Neoplasms
| Article | Year |
|---|---|
[Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineopl | 1995 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; A | 1996 |
2 other studies available for aminoglutethimide and Endometrial Neoplasms
| Article | Year |
|---|---|
Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma.
Topics: Adult; Aminoglutethimide; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Disease-Free Surv | 2003 |
Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Aminoglutethimide; Aromatase Inhibitors; Binding, Competitive; | 1995 |